Processa Pharmaceuticals, Inc.
PCSA
DELAYED 1 MONTH

19 insider filings · Latest: Jul 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 29, 2026Jun 1 9:01 PMYoung DavidDirector, Pres. Research & Development
Purchase
1,786$2.57$4.6K17,131(D)

View →

May 29, 2026Jun 1 8:59 PMRussell SkibstedChief Financial Officer
Purchase
2,292$2.57$5.9K10,758(D)

View →

May 29, 2026Jun 1 8:58 PMGeorge K NgDirector, Chief Executive Officer
Purchase
2,129$2.57$5.5K9,970(D)

View →

May 29, 2026Jun 1 8:56 PMPatrick LinChief Business - Strategy Off
Purchase
1,582$2.57$4.1K9,176(D)

View →

May 29, 2026Jun 1 8:55 PMWendy GuyChief Administrative Officer
Purchase
1,829$2.57$4.7K9,840(D)

View →

May 15, 2026May 19 10:06 PMGeorge K NgDirector, Chief Executive Officer
Purchase
1,843$2.97$5.5K7,841(D)

View →

May 15, 2026May 19 10:04 PMYoung DavidDirector, Pres. Research & Development
Purchase
1,545$2.97$4.6K15,345(D)

View →

May 15, 2026May 19 10:02 PMPatrick LinChief Business - Strategy Off
Purchase
1,369$2.97$4.1K7,594(D)

View →

May 15, 2026May 19 9:37 PMWendy GuyChief Administrative Officer
Purchase
1,583$2.97$4.7K8,011(D)

View →

May 15, 2026May 19 9:35 PMRussell SkibstedChief Financial Officer
Purchase
1,984$2.97$5.9K8,466(D)

View →

Apr 15, 2026May 19 9:31 PMGeorge K NgDirector, Chief Executive Officer
Purchase
1,843$2.97$5.5K3,979(D)

View →

Apr 30, 2026May 19 9:17 PMSian BigoraChief Development Officer
Purchase
1,971$2.71$5.3K7,481(D)

View →

Apr 30, 2026May 1 8:39 PMYoung DavidDirector, Pres. Research & Development
Purchase
1,706$2.69$4.6K13,813(D)

View →

Apr 30, 2026May 1 8:38 PMRussell SkibstedChief Financial Officer
Purchase
2,190$2.69$5.9K6,498(D)

View →

Apr 30, 2026May 1 8:37 PMGeorge K NgDirector, Chief Executive Officer
Purchase
2,034$2.69$5.5K6,013(D)

View →

Apr 30, 2026May 1 8:36 PMPatrick LinChief Business - Strategy Off
Purchase
1,511$2.69$4.1K6,236(D)

View →

Apr 30, 2026May 1 8:35 PMWendy GuyChief Administrative Officer
Purchase
1,748$2.69$4.7K6,441(D)

View →

Apr 30, 2026May 1 8:34 PMSian BigoraChief Development Officer
Purchase
1,986$2.69$5.3K7,496(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 28, 2026Jul 31 1:49 AMSheila GujrathiDirector
Grant/Award
83,123.156—12,311.279(I)

View →